Antimicrobial peptides in the pathogenesis of psoriasis.

The Journal of Dermatology
Shin Morizane, Richard L Gallo

Abstract

One characteristic abnormality of lesional skin in psoriasis is the excessive production of antimicrobial peptides and proteins (AMPs). AMPs typically are small (12-50 amino acids), have positive charge and amphipathic structure, and are found in all living organisms including mammals, insects, plants and invertebrates. These peptides are best known for their integral role in killing pathogenic microorganisms; however, in vertebrates, they are also capable of modifying host inflammatory responses by a variety of mechanisms. In psoriatic lesions, many AMPs are highly expressed, and especially the associations between psoriasis and cathelicidin, β-defensins or S100 proteins have been well studied. Among them, a cathelicidin peptide, LL-37, has been highlighted as a modulator of psoriasis development in recent years. AMPs had been thought to worsen psoriatic lesions but recent evidence has also suggested the possibility that the induction of AMPs expression might improve aspects of the disease. Further investigations are needed to uncover a previously underappreciated role for AMPs in modulating the immune response in psoriasis, and to improve disease without the risks of systemic immunosuppressive approaches.

References

Nov 1, 1991·The British Journal of Dermatology·J FunkL E Hanssen
Dec 12, 1986·JAMA : the Journal of the American Medical Association·C N EllisT M Annesley
Sep 20, 1986·British Medical Journal·C E GriffithsH Valdimarsson
Dec 1, 1985·The Journal of Investigative Dermatology·G D WeinsteinP A Ross
Jan 1, 1995·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J FähG Burg
Oct 1, 1994·Journal of Interferon Research·P SchmidM A Horisberger
Apr 1, 1996·The Journal of Nutrition·M F Holick
Jul 1, 1996·The Journal of Investigative Dermatology·T JinquanK Thestrup-Pedersen
Oct 15, 1996·The Journal of Clinical Investigation·T Wrone-Smith, B J Nickoloff
Mar 1, 1997·Journal of the American Academy of Dermatology·L Kowalzick
Jun 26, 1997·Nature·J HarderJ M Schröder
Jun 1, 2000·Current Pharmaceutical Design·K Fogh, K Kragballe
Sep 6, 2000·Clinical and Experimental Dermatology·A M Downs, M G Dunnill
Nov 22, 2000·The Journal of Biological Chemistry·J HarderJ M Schroder
Dec 29, 2000·Nature·H HemmiS Akira
Oct 11, 2002·The New England Journal of Medicine·Peck Y OngDonald Y M Leung
Apr 11, 2003·Lancet·Mark Lebwohl
Jun 5, 2003·The Journal of Clinical Investigation·Rembert KoczullaRobert Bals
Sep 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ichiro NomuraDonald Y M Leung
Dec 18, 2003·JAMA : the Journal of the American Medical Association·Janet M TorpyRichard M Glass
Jan 7, 2004·The Journal of Experimental Medicine·Edmund LeeJames G Krueger
Feb 14, 2004·The Journal of Investigative Dermatology·Leslie van der FitsMartie C M Verschuren
Apr 17, 2004·The Journal of Investigative Dermatology·Sari SuomelaUlpu Saarialho-Kere
May 15, 2004·Immunity·Jacques BanchereauA Karolina Palucka
Jun 12, 2004·The Journal of Investigative Dermatology·Richard L EckertKathleen Lee
Aug 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tian-Tian WangJohn H Hanrahan
Nov 30, 2004·Nature Immunology·Regine GläserJens-Michael Schröder
Jan 5, 2005·Journal of Leukocyte Biology·Jürgen Harder, Jens-Michael Schröder
Mar 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marissa H BraffRichard L Gallo
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lloyd S MillerRobert L Modlin
Jul 7, 2005·The Journal of Experimental Medicine·Frank O NestleMichel Gilliet
Sep 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sho TokumaruKoji Hashimoto
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gamze PiskinMarcel B M Teunissen
Feb 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Neeloffer MookherjeeRobert E W Hancock
Nov 1, 1990·The Journal of Investigative Dermatology·C E Griffiths, J J Voorhees
Sep 20, 2006·The Journal of Experimental Medicine·Spencer C LiangLynette A Fouser
Sep 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eiko ToichiKevin D Cooper
Oct 3, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kenshi YamasakiRichard L Gallo
Oct 28, 2006·The Journal of Investigative Dermatology·Maria C LebreEsther C de Jong
Feb 9, 2007·The New England Journal of Medicine·Gerald G KruegerUNKNOWN CNTO 1275 Psoriasis Study Group

❮ Previous
Next ❯

Citations

Mar 29, 2014·Advances in Wound Care·Tongyu Cao WikramanayakeMarjana Tomic-Canic
Mar 25, 2014·Annual Review of Immunology·Michelle A LowesJames G Krueger
Dec 19, 2013·International Immunology·Masayuki IshizakiTadashi Matsuda
Sep 10, 2014·Mediators of Inflammation·Young Ji HwangKyu Joong Ahn
Jun 6, 2014·Journal of Immunology Research·A Batycka-BaranJ C Szepietowski
Jan 31, 2016·Medical Hypotheses·Marijana VičićLarisa Prpić-Massari
Jan 8, 2013·Trends in Immunology·Michelle A LowesJames G Krueger
Mar 8, 2016·Journal of the American Academy of Dermatology·Ellen S HaddockWynnis L Tom
Jun 10, 2015·Journal of Dermatological Science·Aleksandra Batycka-BaranRonald Wolf
Mar 15, 2016·The Journal of Dermatology·Carlo MattozziStefano Calvieri
Mar 27, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·R A RaposoW Liao
Mar 31, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Andrew Johnston
Nov 29, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·T Gambichler, M Skrygan
Feb 3, 2015·Clinical and Experimental Dermatology·L H ElgarhyS M Moustafa
Apr 25, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Anders Elm PedersenBo Bang
Mar 10, 2015·Annales de dermatologie et de vénéréologie·F HacardF Bérard
Oct 19, 2014·Seminars in Immunopathology·Satoshi NakamizoKenji Kabashima
Oct 4, 2013·Pharmacogenomics·Rocío Prieto-PérezFrancisco Abad-Santos
Oct 13, 2014·Journal of Dermatological Science·Suzanna SalzerJürgen Schauber
Oct 25, 2016·The Journal of Investigative Dermatology·Bingjie WangDonald J Davidson
Dec 12, 2017·The Journal of Dermatology·Eisaku OgawaRyuhei Okuyama
Aug 8, 2018·Immunotherapy·Christine Bangert, Tamara Kopp
Aug 28, 2018·Clinical and Experimental Dermatology·X WangY Zheng
Sep 11, 2018·International Journal of Dermatology·Ibrahim ElgharibMona M Sharaf
Sep 12, 2018·Journal of Cellular Biochemistry·Mariagrazia GranataFabio D'Amico
Oct 19, 2019·Expert Opinion on Drug Metabolism & Toxicology·Anna CampanatiAnnamaria Offidani
Dec 31, 2019·The British Journal of Dermatology·K Kridin, A D Cohen
Jan 9, 2020·Nature Communications·Franziska HersterAlexander N R Weber
Apr 29, 2020·EMBO Reports·Elien Van NuffelRudi Beyaert
Oct 28, 2019·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·Tugba Kevser UzuncakmakSerpil Oguztuzun
May 18, 2020·Clinical and Experimental Immunology·Y LuoK Suzuki
Jan 8, 2016·Experimental Dermatology·Maria Luisa MangoniMichael Zasloff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.